Hyaluronan regulates bone morphogenetic protein-7-dependent prevention and reversal of myofibroblast phenotype

Journal of Biological Chemistry

Volumn 290, Issue 18, 2015, Pages 11218-11234

  Midgley, Adam C ^a   Duggal, Lucy ^a   Jenkins, Robert ^a   Hascall, Vincent ^b   Steadman, Robert ^a   Phillips, Aled O ^a   Meran, Soma ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CELL MEMBRANES; PROTEINS;

BONE MORPHOGENETIC PROTEIN-7; CELL SURFACES; ENDOSOMES; HYALURONAN; MYOFIBROBLASTS; POTENTIAL TARGETS;

HYALURONIC ACID;

ALPHA SMOOTH MUSCLE ACTIN; CD44V ANTIGEN; CD44V7 ANTIGEN; CD44V8 ANTIGEN; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIDASE; HYALURONIDASE 1; HYALURONIDASE 2; OSTEOGENIC PROTEIN 1; SODIUM PROTON EXCHANGE PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; CATION TRANSPORT PROTEIN; GLUCURONOSYLTRANSFERASE; HAS2 PROTEIN, HUMAN; HYALURONOGLUCOSAMINIDASE; MESSENGER RNA; SLC9A1 PROTEIN, HUMAN; SODIUM PROTON EXCHANGE PROTEIN;

ACTIN FILAMENT; ALPHA SMA GENE; ARTICLE; CD44 GENE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISSOLUTION; ENDOSOME; GENE; GENE EXPRESSION REGULATION; HAS1 GENE; HAS2 GENE; HAS3 GENE; HUMAN; HUMAN CELL; HYAL1 GENE; HYAL2 GENE; INTERNALIZATION; MYOFIBROBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UPREGULATION; CYTOLOGY; FIBROBLAST; GENETICS; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANTIGENS, CD44; BIOLOGICAL TRANSPORT; BONE MORPHOGENETIC PROTEIN 7; CATION TRANSPORT PROTEINS; CELL DIFFERENTIATION; ENDOSOMES; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; MYOFIBROBLASTS; PHENOTYPE; RNA, MESSENGER; SODIUM-HYDROGEN ANTIPORTER;

EID: 84929485490     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.625939     Document Type: Article

References (86)

1. Hruska, K. A., Guo, G., Wozniak, M., Martin, D., Miller, S., Liapis, H., Loveday, K., Klahr, S., Sampath, T. K., and Morrissey, J. (2000) Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am. J. Physiol. Renal. Physiol. 279, F130-F143
2. Zeisberg, M., Hanai, J., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., and Kalluri, R. (2003) BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med. 9, 964-968
3. Vukicevic, S., Basic, V., Rogic, D., Basic, N., Shih, M. S., Shepard, A., Jin, D., Dattatreyamurty, B., Jones, W., Dorai, H., Ryan, S., Griffiths, D., Maliakal, J., Jelic, M., Pastorcic, M., Stavljenic, A., and Sampath, T. K. (1998) Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J. Clin. Invest. 102, 202-214
4. Wang, S., Chen, Q., Simon, T. C., Strebeck, F., Chaudhary, L., Morrissey, J., Liapis, H., Klahr, S., and Hruska, K. A. (2003) Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int. 63, 2037-2049
5. Kinoshita, K., Iimuro, Y., Otogawa, K., Saika, S., Inagaki, Y., Nakajima, Y., Kawada, N., Fujimoto, J., Friedman, S. L., andIkeda, K. (2007) Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut 56, 706-714
6. Myllärniemi, M., Lindholm, P., Ryynänen, M. J., Kliment, C. R., Salmen-kivi, K., Keski-Oja, J., Kinnula, V. L., Oury, T. D., and Koli, K. (2008) Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis. Am. J.Respir. Crit. CareMed. 177, 321-329
7. Yang, G., Zhu, Z., Wang, Y., Gao, A., Niu, P., and Tian, L. (2013) Bone morphogenetic protein-7 inhibits silica-induced pulmonary fibrosis in rats. Toxicol. Lett. 220, 103-108
8. Buijs, J. T., Petersen, M., van der Horst, G., and van der Pluijm, G. (2010) Bone morphogenetic proteins and its receptors; therapeutic targets in cancer progression and bone metastasis? Curr. Pharm. Des. 16, 1291-1300
9. Rees, J. R., Onwuegbusi, B. A., Save, V. E., Alderson, D., and Fitzgerald, R. C. (2006) In vivo and in vitro evidence for transforming growth factor-β1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma. Cancer Res. 66, 9583-9590
10. Luo, D. D., Phillips, A., and Fraser, D. (2010) Bone morphogenetic pro-tein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression. Am. J. Pathol. 176, 1139-1147
11. Motazed, R., Colville-Nash, P., Kwan, J. T., and Dockrell, M. E. (2008) BMP-7 and proximal tubule epithelial cells: activation of multiple signaling pathways reveals a novel anti-fibrotic mechanism. Pharm. Res. 25, 2440-2446
12. Simpson, R. M., Wells, A., Thomas, D., Stephens, P., Steadman, R., and Phillips, A. (2010) Aging fibroblasts resist phenotypic maturation because of impaired hyaluronan-dependent CD44/epidermal growth factor receptor signaling. Am. J. Pathol. 176, 1215-1228
13. DeGrendele, H. C, Estess, P., Picker, L. J., and Siegelman, M. H. (1996) CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med. 183, 1119-1130
14. DeGrendele, H. C, Estess, P., and Siegelman, M. H. (1997) Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 278, 672-675
15. Cuff, C. A., Kothapalli, D., Azonobi, I., Chun, S., Zhang, Y., Belkin, R., Yeh, C, Secreto, A., Assoian, R. K., Rader, D. J, and Puré, E. (2001) The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J. Clin. Invest. 108, 1031-1040
16. Clark, R. A., Alon, R., and Springer, T. A. (1996) CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J. Cell Biol. 134, 1075-1087
17. Nishikawa, K., Andres, G., Bhan, A. K., McCluskey, R. T., Collins, A. B., Stow, J. L., and Stamenkovic, I. (1993) Hyaluronate is a component of crescents in rat autoimmune glomerulonephritis. Lab. Invest. 68, 146-153
18. Johnsson, C, Tufveson, G., Wahlberg, J., and Hällgren, R. (1996) Experimentally-induced warm renal ischemia induces cortical accumulation of hyaluronan in the kidney. Kidney Int. 50, 1224-1229
19. Lewis, A., Steadman, R., Manley, P., Craig, K., de la Motte, C, Hascall, V., and Phillips, A. O. (2008) Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosis. Histol. Histopathol. 23, 731-739
20. Sano, N, Kitazawa, K., and Sugisaki, T. (2001) Localization and roles of CD44, hyaluronic acid and osteopontin in IgA nephropathy. Nephron 89, 416-421
21. Zaman, A., Cui, Z., Foley, J. P., Zhao, H., Grimm, P. C, Delisser, H. M., and Savani, R. C. (2005) Expression and role of the hyaluronan receptor RHAMM in inflammation after bleomycin injury. Am. J. Respir. CellMol. Biol. 33, 447-454
22. Bjermer, L., Lundgren, R., and Hällgren, R. (1989) Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. Thorax 44, 126-131
23. Stickel, F., Poeschl, G., Schuppan, D., Conradt, C, Strenge-Hesse, A., Fuchs, F. S., Hofmann, W. J., and Seitz, H. K. (2003) Serum hyaluronate correlates with histological progression in alcoholic liver disease. Eur. J. Gastroenterol. Hepatol. 15, 945-950
24. Nyberg, A., Engström-Laurent, A., and Lööf, L. (1988) Serum hyaluronate in primary biliary cirrhosis-a biochemical marker for progressive liver damage. Hepatology 8, 142-146
25. Meran, S., Luo, D. D., Simpson, R., Martin, J., Wells, A., Steadman, R., and Phillips, A. O. (2011) Hyaluronan facilitates transforming growth factor-β1-dependent proliferation via CD44 and epidermal growth factor receptor interaction. J. Biol. Chem. 286, 17618-17630
26. Webber, J., Meran, S., Steadman, R., and Phillips, A. (2009) Hyaluronan orchestrates transforming growth factor-β1-dependent maintenance of myofibroblast phenotype. J. Biol. Chem. 284, 9083-9092
27. Midgley, A. C, Rogers, M., Hallett, M. B., Clayton, A., Bowen, T., Phillips, A. O., and Steadman, R. (2013) Transforming growth factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts. J. Biol. Chem. 288, 14824-14838
28. Meran, S., Martin, J., Luo, D. D., Steadman, R., and Phillips, A. (2013) Interleukin-1β induces hyaluronan and CD44-dependent cell protrusions that facilitate fibroblast-monocyte binding.Am. J. Pathol. 182, 2223-2240
29. Selbi, W., de la Motte, C A., Hascall, V. C, Day, A. J., Bowen, T., and Phillips, A. O. (2006) Characterization of hyaluronan cable structure and function in renal proximal tubular epithelial cells. Kidney Int. 70, 1287-1295
30. Andhare, R. A., Takahashi, N, Knudson, W., and Knudson, C. B. (2009) Hyaluronan promotes the chondrocyte response to BMP-7. Osteoarthritis Cartilage 17, 906-916
31. Peterson, R. S., Andhare, R. A., Rousche, K. T., Knudson, W., Wang, W., Grossfield, J. B., Thomas, R. O., Hollingsworth, R. E., and Knudson, C. B. (2004) CD44 modulates Smad1 activation in the BMP-7 signaling pathway. J. Cell Biol. 166, 1081-1091
32. Selbi, W., de la Motte, C, Hascall, V., and Phillips, A. (2004) BMP-7 modulates hyaluronan-mediated proximal tubular cell-monocyte interaction. J. Am. Soc. Nephrol. 15, 1199-1211
33. Meran, S., Thomas, D., Stephens, P., Martin, J., Bowen, T., Phillips, A., and Steadman, R. (2007) Involvement of hyaluronan in regulation of fibroblast phenotype. J. Biol. Chem. 282, 25687-25697
34. Meran, S., Thomas, D. W., Stephens, P., Enoch, S., Martin, J., Steadman, R., and Phillips, A. O. (2008) Hyaluronan facilitates transforming growth fac-tor-β1-mediated fibroblast proliferation. J. Biol. Chem. 283, 6530-6545
35. Chen, L., Neville, R. D., Michael, D. R., Martin, J., Luo, D. D., Thomas, D. W., Phillips, A. O., and Bowen, T. (2012) Identification and analysis of the human hyaluronan synthase 1 gene promoter reveals Smad3-and Sp3-mediated transcriptional induction. Matrix Biol. 31, 373-379
36. Stern, R. (2003) Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology 13, 105R-115R
37. Petrey, A. C, and de la Motte, C. A. (2014) Hyaluronan, a crucial regulator of inflammation. Front. Immunol. 5, 101
38. Ito, T., Williams, J. D., Fraser, D. J., and Phillips, A. O. (2004) Hyaluronan regulates transforming growth factor-β1 receptor compartmentalization. J. Biol. Chem. 279, 25326-25332
39. Rampanelli, E., Rouschop, K. M., Claessen, N, Teske, G. J., Pals, S. T., Leemans, J. C, and Florquin, S. (2014) Opposite role of CD44-standard and CD44-variant-3 in tubular injury and development of renal fibrosis during chronic obstructive nephropathy. Kidney Int. 86, 558-569
40. Matuschek, C, Lehnhardt, M., Gerber, P. A., Poremba, C, Hamilton, J., Lammering, G., Orth, K., Budach, W., Bojar, H., Bölke, E., and Peiper, M. (2014) Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study. Eur. J. Med. Res. 19, 6
41. Olsson, E., Honeth, G., Bendahl, P. O., Saal, L. H, Gruvberger-Saal, S., Ringnér, M., Vallon-Christersson, J., Jönsson, G., Holm, K., Lövgren, K., Fernö, M., Grabau, D., Borg, A., andHegardt, C (2011) CD44isoformsare heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers. BMC Cancer 11, 418
42. Lepperdinger, G., Strobl, B., and Kreil, G. (1998) HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J. Biol. Chem. 273, 22466-22470
43. Rai, S. K., Duh, F. M., Vigdorovich, V., Danilkovitch-Miagkova, A., Ler-man, M. I., and Miller, A. D. (2001) Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for Jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc. Natl. Acad. Sci. U.S.A. 98, 4443-4448
44. Bourguignon, L. Y., Singleton, P. A., Diedrich, F., Stern, R., and Gilad, E. (2004) CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J. Biol. Chem. 279, 26991-27007
45. Anscher, M. S., Peters, W. P., Reisenbichler, H, Petros, W. P., and Jirtle, R. L. (1993) Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl. J. Med. 328, 1592-1598
46. Border, W. A., and Noble, N. A. (1994) Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 331, 1286-1292
47. Border, W. A., and Ruoslahti, E. (1992) Transforming growth factor-β in disease: the dark side of tissue repair. J. Clin. Invest. 90, 1-7
48. Vaughan, M. B., Howard, E. W., and Tomasek, J. J. (2000) Transforming growth factor-β1 promotes the morphological and functional differentiation of the myofibroblast. Exp. CellRes. 257, 180-189
49. Gabbiani, G. (2003) The myofibroblast in wound healing and fibrocon-nective tissue disease. J. Pathol. 200, 500-503
50. Desmoulière, A., Darby, I. A., and Gabbiani, G. (2003) Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab. Invest. 83, 1689-1707
51. Goumenos, D., Tsomi, K., Iatrou, C., Oldroyd, S., Sungur, A., Papaioan-nides, D., Moustakas, G., Ziroyannis, P., Mountokalakis, T., and El Nahas, A. M. (1998) Myofibroblasts and the progression of crescentic glomerulonephritis. Nephrol. Dial. Transplant. 13, 1652-1661
52. Goumenos, D. S., Brown, C. B., Shortland, J., and el Nahas, A. M. (1994) Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol. Dial. Transplant. 9, 1418-1425
53. Hashimoto, N, Jin, H, Liu, T., Chensue, S. W., andPhan, S. H. (2004) Bone marrow-derived progenitor cells in pulmonary fibrosis. J. Clin. Invest. 113, 243-252
54. Simpson, R. M., Meran, S., Thomas, D., Stephens, P., Bowen, T., Stead-man, R., and Phillips, A. (2009) Age-related changes in pericellular hyalu-ronan organization leads to impaired dermal fibroblast to myofibroblast differentiation. Am. J. Pathol. 175, 1915-1928
55. Banerji, S., Day, A. J., Kahmann, J. D., and Jackson, D. G. (1998) Characterization of a functional hyaluronan-binding domain from the human CD44 molecule expressed in Escherichia coli. Protein Expr. Purif. 14, 371-381
56. Wang, Q., Teder, P., Judd, N P., Noble, P. W., andDoerschuk, C.M. (2002) CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice. Am. J. Pathol. 161, 2219-2228
57. Bourguignon, L. Y., Zhu, D., and Zhu, H. (1998) CD44 isoform-cytoskel-eton interaction in oncogenic signaling and tumor progression. Front. Biosci. 3, d637-d649
58. de La Motte, C. A., Hascall, V. C., Calabro, A., Yen-Lieberman, B., and Strong, S. A. (1999) Mononuclear leukocytes preferentially bind via CD44 to hyaluronan on human intestinal mucosal smooth muscle cells after virus infection or treatment with poly(IC). J. Biol. Chem. 274, 30747-30755
59. Banerji, S., Wright, A. J., Noble, M., Mahoney, D. J., Campbell, I. D., Day, A. J., and Jackson, D. G. (2007) Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction. Nat. Struct. Mol. Biol. 14, 234-239
60. Teriete, P., Banerji, S., Noble, M., Blundell, C. D., Wright, A. J., Pickford, A. R., Lowe, E., Mahoney, D. J., Tammi, M. I., Kahmann, J. D., Campbell, I. D., Day, A. J., and Jackson, D. G. (2004) Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Mol. Cell 13, 483-496
61. Misra, S., Hascall, V. C, De Giovanni, C, Markwald, R. R., and Ghatak, S. (2009) Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ mice. J. Biol. Chem. 284, 12432-12446
62. Guo, W., and Frenette, P. S. (2014) Alternative CD44 splicing in intestinal stem cells and tumorigenesis. Oncogene 33, 537-538
63. Seiter, S., Schmidt, D. S., and Zöller, M. (2000) The CD44 variant isoforms CD44v6 and CD44v7 are expressed by distinct leukocyte subpopulations and exert non-overlapping functional activities. Int. Immunol. 12, 37-49
64. Zöller, M. (1995) CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation. J. Mol. Med. 73, 425-438
65. Kasper, M., Günthert, U., Dall, P., Kayser, K., Schuh, D., Haroske, G., and Müller, M. (1995) Distinct expression patterns of CD44 isoforms during human lung development and in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 13, 648-656
66. Knudson, W., Chow, G., and Knudson, C. B. (2002) CD44-mediated uptake and degradation of hyaluronan. Matrix Biol. 21, 15-23
67. Sleeman, J., Rudy, W., Hofmann, M., Moll, J., Herrlich, P., and Ponta, H. (1996) Regulated clustering of variant CD44 proteins increases their hya-luronate binding capacity. J. Cell Biol. 135, 1139-1150
68. Wolny, P. M., Banerji, S., Gounou, C, Brisson, A. R., Day, A. J., Jackson, D. G., and Richter, R. P. (2010) Analysis of CD44-hyaluronan interactions in an artificial membrane system: insights into the distinct binding properties of high and low molecular weight hyaluronan. J. Biol. Chem. 285, 30170-30180
69. Lesley, J., Hascall, V. C, Tammi, M., and Hyman, R. (2000) Hyaluronan binding by cell surface CD44.J. Biol. Chem. 275, 26967-26975
70. Hsu, L. J., Schultz, L., Hong, Q., Van Moer, K., Heath, J., Li, M. Y., Lai, F. J., Lin, S. R., Lee, M. H., Lo, C. P., Lin, Y. S., Chen, S. T., and Chang, N S. (2009) Transforming growth factor β1 signaling via interaction with cell surface Hyal-2 and recruitment of WWOX/WOX1. J. Biol. Chem. 284, 16049-16059
71. Duterme, C, Mertens-Strijthagen, J., Tammi, M., and Flamion, B. (2009) Two novel functions of hyaluronidase-2 (Hyal2) are formation of the gly-cocalyx and control of CD44-ERM interactions. J. Biol. Chem. 284, 33495-33508
72. Tammi, R., Rilla, K., Pienimaki, J. P., MacCallum, D. K., Hogg, M., Luuk-konen, M., Hascall, V. C, and Tammi, M. (2001) Hyaluronan enters kera-tinocytes by a novel endocytic route for catabolism. J. Biol. Chem. 276, 35111-35122
73. Csoka, A. B., Frost, G. I., and Stern, R. (2001) The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 20, 499-508
74. Evanko, S. P., and Wight, T. N. (1999) Intracellular localization of hyaluronan in proliferating cells. J. Histochem. Cytochem. 47, 1331-1342
75. Pienimaki, J. P., Rilla, K., Fulop, C, Sironen, R. K., Karvinen, S., Pasonen, S., Lammi, M. J., Tammi, R., Hascall, V. C, and Tammi, M. I. (2001) Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratino-cytes and increases pericellular and intracellular hyaluronan. J. Biol. Chem. 276, 20428-20435
76. Margolis, R. K., Crockett, C. P., Kiang, W. L., and Margolis, R. U. (1976) Glycosaminoglycans and glycoproteins associated with rat brain nuclei. Biochim. Biophys. Acta 451, 465-469
77. Furukawa, K., and Terayama, H. (1977) Isolation and identification of glycosaminoglycans associated with purified nuclei from rat liver. Biochim. Biophys. Acta 499, 278-289
78. Londoño, I., and Bendayan, M. (1988) High-resolution cytochemistry of neuraminic and hexuronic acid-containing macromolecules applying the enzyme-gold approach. J. Histochem. Cytochem. 36, 1005-1014
79. Ripellino, J. A., Margolis, R. U., and Margolis, R. K. (1989) Immunoelec-tron microscopic localization of hyaluronic acid-binding region and link protein epitopes in brain. J. Cell Biol. 108, 1899-1907
80. Kan, F. W. (1990) High-resolution localization of hyaluronic acid in the golden hamster oocyte-cumulus complex by use of a hyaluronidase-gold complex. Anat. Rec. 228, 370-382
81. Eggli, P. S., and Graber, W. (1995) Association of hyaluronan with rat vascular endothelial and smooth muscle cells. J. Histochem. Cytochem. 43, 689-697
82. Evanko, S. P., Parks, W. T., and Wight, T. N. (2004) Intracellular hyaluronan in arterial smooth muscle cells: association with microtubules, RHAMM, and the mitotic spindle. J. Histochem. Cytochem. 52, 1525-1535
83. Wang, A., de la Motte, C, Lauer, M., and Hascall, V. (2011) Hyaluronan matrices in pathobiological processes. FEBSJ. 278, 1412-1418
84. Vigetti, D., Genasetti, A., Karousou, E., Viola, M., Clerici, M., Bartolini, B., Moretto, P., De Luca, G., Hascall, V C, and Passi, A. (2009) Modulation of hyaluronan synthase activity in cellular membrane fractions. J. Biol. Chem. 284, 30684-30694
85. Ren, J., Hascall, V. C, and Wang, A. (2009) Cyclin D3 mediates synthesis of a hyaluronan matrix that is adhesive for monocytes in mesangial cells stimulated to divide in hyperglycemic medium. J. Biol. Chem. 284, 16621-16632
86. Miletti-González, K. E., Murphy, K., Kumaran, M. N, Ravindranath, A. K., Wernyj, R. P., Kaur, S., Miles, G. D., Lim, E., Chan, R., Chekmareva, M., Heller, D. S., Foran, D., Chen, W., Reiss, M., Bandera, E. V, Scotto, K., and Rodríguez-Rodríguez, L. (2012) Identification of function for CD44intra-cytoplasmic domain (CD44-ICD): modulation of matrix metalloprotei-nase 9 (MMP-9) transcription via novel promoter response element. J. Biol. Chem. 287, 18995-19007